BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taub R. Blocking NF-kappaB in the liver: the good and bad news. Hepatology. 1998;27:1445-1446. [PMID: 9581706 DOI: 10.1002/hep.510270538] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Trejo-solís C, Chagoya de Sánchez V, Aranda-fraustro A, Sánchez-sevilla L, Gómez-ruíz C, Hernández-muñoz R. Inhibitory Effect of Vitamin E Administration on the Progression of Liver Regeneration Induced by Partial Hepatectomy in Rats. Lab Invest 2003;83:1669-79. [DOI: 10.1097/01.lab.0000095688.89364.bf] [Cited by in Crossref: 28] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
2 Galun E, Axelrod JH. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta. 2002;1592:345-358. [PMID: 12421677 DOI: 10.1016/s0167-4889(02)00326-9] [Cited by in Crossref: 81] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
3 Schenker S, Hoyumpa AM. New concepts of dietary intervention in alcoholic liver disease. Journal of Laboratory and Clinical Medicine 1999;134:433-6. [DOI: 10.1016/s0022-2143(99)90162-2] [Cited by in Crossref: 5] [Article Influence: 0.2] [Reference Citation Analysis]
4 Uchida Y, Ke B, Freitas MC, Yagita H, Akiba H, Busuttil RW, Najafian N, Kupiec-Weglinski JW. T-cell immunoglobulin mucin-3 determines severity of liver ischemia/reperfusion injury in mice in a TLR4-dependent manner. Gastroenterology 2010;139:2195-206. [PMID: 20637206 DOI: 10.1053/j.gastro.2010.07.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 7.5] [Reference Citation Analysis]
5 Zhang J, Yamaguchi Y, Mori K, Okabe K, Hidaka H, Ohshiro H, Uchino S, Ishihara K, Furuhashi T, Yamada S, Ogawa M. A Serine Protease Inhibitor, N-α-Tosyl-l-lysine Chloromethyl Ketone, Prolongs Rat Hepatic Allograft Survival. Journal of Surgical Research 2001;96:296-303. [DOI: 10.1006/jsre.2000.6065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
6 Stumptner C, Fuchsbichler A, Heid H, Zatloukal K, Denk H. Mallory body-A disease-associated type of sequestosome: Mallory body-A disease-associated type of sequestosome. Hepatology 2002;35:1053-62. [DOI: 10.1053/jhep.2002.32674] [Cited by in Crossref: 109] [Cited by in F6Publishing: 96] [Article Influence: 6.1] [Reference Citation Analysis]
7 Ricciardi R, Shah SA, Wheeler SM, Quarfordt SH, Callery MP, Meyers WC, Chari RS. Regulation of NFkappaB in hepatic ischemic preconditioning. J Am Coll Surg. 2002;195:319-326. [PMID: 12229938 DOI: 10.1016/s1072-7515(02)01229-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
8 Galun E, Zeira E, Pappo O, Peters M, Rose-John S. Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J. 2000;14:1979-1987. [PMID: 11023982 DOI: 10.1096/fj.99-0913com] [Cited by in Crossref: 87] [Cited by in F6Publishing: 75] [Article Influence: 4.1] [Reference Citation Analysis]
9 Martin-Sanz P, Hortelano S, Callejas NA, Goren N, Casado M, Zeini M, Boscá L. Nitric oxide in liver inflammation and regeneration. Metab Brain Dis 2002;17:325-34. [PMID: 12602509 DOI: 10.1023/a:1021909902310] [Cited by in Crossref: 17] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
10 Jura J, Węgrzyn P, Zarębski A, Władyka B, Koj A. Identification of changes in the transcriptome profile of human hepatoma HepG2 cells stimulated with interleukin-1 beta. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2004;1689:120-33. [DOI: 10.1016/j.bbadis.2004.03.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
11 Lavon I, Goldberg I, Amit S, Landsman L, Jung S, Tsuberi BZ, Barshack I, Kopolovic J, Galun E, Bujard H, Ben-Neriah Y. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med 2000;6:573-7. [PMID: 10802715 DOI: 10.1038/75057] [Cited by in Crossref: 128] [Cited by in F6Publishing: 126] [Article Influence: 6.1] [Reference Citation Analysis]
12 Uchida Y, Ke B, Freitas MC, Ji H, Zhao D, Benjamin ER, Najafian N, Yagita H, Akiba H, Busuttil RW, Kupiec-Weglinski JW. The emerging role of T cell immunoglobulin mucin-1 in the mechanism of liver ischemia and reperfusion injury in the mouse. Hepatology 2010;51:1363-72. [PMID: 20091883 DOI: 10.1002/hep.23442] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
13 Zhao L, Liang J, Rao W, Cui M, Ren S, Zhang L, Xu D, Han Q, Zang YJ, Zhang B. Cross-regulation by TLR4 and T cell Ig mucin-3 determines severity of liver injury in a CCl4-induced mouse model. Scand J Immunol 2020;91:e12851. [PMID: 31733121 DOI: 10.1111/sji.12851] [Reference Citation Analysis]
14 Arsura M, Cavin LG. Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett. 2005;229:157-169. [PMID: 16125305 DOI: 10.1016/j.canlet.2005.07.008] [Cited by in Crossref: 118] [Cited by in F6Publishing: 114] [Article Influence: 7.4] [Reference Citation Analysis]
15 Bilbao G, Contreras JL, Zhang HG, Pike MJ, Overturf K, Mikheeva G, Krasnykh V, Curiel DT. Adenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene. J Virol 1999;73:6992-7000. [PMID: 10400798 DOI: 10.1128/JVI.73.8.6992-7000.1999] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
16 Qin JM, Fu XY, Li SJ, Liu SQ, Zeng JZ, Qiu XH, Wu MC, Wang HY. Gene and protein expressions of p28GANK in rat with liver regeneration. World J Gastroenterol 2003; 9(11): 2523-2527 [PMID: 14606089 DOI: 10.3748/wjg.v9.i11.2523] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
17 Vasiliou V, Qamar L, Pappa A, Sophos NA, Petersen DR. Involvement of the electrophile responsive element and p53 in the activation of hepatic stellate cells as a response to electrophile menadione. Arch Biochem Biophys. 2003;413:164-171. [PMID: 12729613 DOI: 10.1016/S0003-9861(03)00095-X] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
18 Skarpen E, Oksvold MP, Grøsvik H, Widnes C, Huitfeldt HS. Altered regulation of EGF receptor signaling following a partial hepatectomy. J Cell Physiol. 2005;202:707-716. [PMID: 15389569 DOI: 10.1002/jcp.20171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
19 de la Coste A, Fabre M, McDonell N, Porteu A, Gilgenkrantz H, Perret C, Kahn A, Mignon A. Differential protective effects of Bcl-xL and Bcl-2 on apoptotic liver injury in transgenic mice. Am J Physiol 1999;277:G702-8. [PMID: 10484397 DOI: 10.1152/ajpgi.1999.277.3.G702] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.5] [Reference Citation Analysis]
20 Müller T, Langner C, Fuchsbichler A, Heinz-erian P, Ellemunter H, Schlenck B, Bavdekar AR, Pradhan AM, Pandit A, Müller-höcker J, Melter M, Kobayashi K, Nagasaka H, Kikuta H, Müller W, Tanner MS, Sternlieb I, Zatloukal K, Denk H. Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 2004;39:963-9. [DOI: 10.1002/hep.20108] [Cited by in Crossref: 56] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
21 Vasiliou V, Lee J, Pappa A, Petersen DR. Involvement of p65 in the regulation of NF-kappaB in rat hepatic stellate cells during cirrhosis. Biochem Biophys Res Commun 2000;273:546-50. [PMID: 10873642 DOI: 10.1006/bbrc.2000.2993] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
22 Li X, Meng Y, Yang XS, Mi LF, Cai SX. ACEI attenuates the progression of CCl4-induced rat hepatic fibrogenesis by inhibiting TGF-β1, PDGF-BB, NF-κB and MMP-2,9. World J Gastroenterol 2005; 11(31): 4807-4811 [PMID: 16097048 DOI: 10.3748/wjg.v11.i31.4807] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
23 Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. Journal of Hepatology 1998;29:836-47. [DOI: 10.1016/s0168-8278(98)80269-9] [Cited by in Crossref: 189] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
24 Talarmin H, Rescan C, Cariou S, Glaise D, Zanninelli G, Bilodeau M, Loyer P, Guguen-Guillouzo C, Baffet G. The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes. Mol Cell Biol 1999;19:6003-11. [PMID: 10454547 DOI: 10.1128/MCB.19.9.6003] [Cited by in Crossref: 199] [Cited by in F6Publishing: 57] [Article Influence: 9.0] [Reference Citation Analysis]
25 Sonis ST. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med. 2002;13:380-389. [PMID: 12393757 DOI: 10.1177/154411130201300502] [Cited by in Crossref: 143] [Cited by in F6Publishing: 132] [Article Influence: 7.9] [Reference Citation Analysis]
26 Strowitzki MJ, Ritter AS, Kimmer G, Schneider M. Hypoxia-adaptive pathways: A pharmacological target in fibrotic disease? Pharmacol Res 2019;147:104364. [PMID: 31376431 DOI: 10.1016/j.phrs.2019.104364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Li D, Friedman S. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy. Journal of Gastroenterology and Hepatology 1999;14:618-33. [DOI: 10.1046/j.1440-1746.1999.01928.x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Lee B, Park S, Kang K, Park R, Kim I. NF-κB activates fibronectin gene expression in rat hepatocytes. Biochemical and Biophysical Research Communications 2002;297:1218-24. [DOI: 10.1016/s0006-291x(02)02356-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
29 Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 1999;18:6910-6924. [PMID: 10602466 DOI: 10.1038/sj.onc.1203238] [Cited by in Crossref: 871] [Cited by in F6Publishing: 844] [Article Influence: 41.5] [Reference Citation Analysis]
30 Guiraud S, Davies KE. Pharmacological advances for treatment in Duchenne muscular dystrophy. Current Opinion in Pharmacology 2017;34:36-48. [DOI: 10.1016/j.coph.2017.04.002] [Cited by in Crossref: 94] [Cited by in F6Publishing: 76] [Article Influence: 23.5] [Reference Citation Analysis]
31 Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol. 1999;14:618-633. [PMID: 10440206 DOI: 10.1046/j.1440-1746.1999.01928.x] [Cited by in Crossref: 255] [Cited by in F6Publishing: 247] [Article Influence: 11.6] [Reference Citation Analysis]
32 Kucharczak J, Simmons MJ, Fan Y, Gélinas C. To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene. 2003;22:8961-8982. [PMID: 14663476 DOI: 10.1038/sj.onc.1207230] [Cited by in Crossref: 534] [Cited by in F6Publishing: 513] [Article Influence: 31.4] [Reference Citation Analysis]
33 Reynaert H, Burt A, Geerts A. Prions in activated hepatic stellate cells: not a surprise after all. Journal of Hepatology 2000;33:838-41. [DOI: 10.1016/s0168-8278(00)80318-9] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
34 Harada N, Hatano E, Koizumi N, Nitta T, Yoshida M, Yamamoto N, Brenner DA, Yamaoka Y. Akt activation protects rat liver from ischemia/reperfusion injury1. Journal of Surgical Research 2004;121:159-70. [DOI: 10.1016/j.jss.2004.04.016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.1] [Reference Citation Analysis]
35 Beraza N, Lüdde T, Assmus U, Roskams T, Vander Borght S, Trautwein C. Hepatocyte-specific IKK gamma/NEMO expression determines the degree of liver injury. Gastroenterology. 2007;132:2504-2517. [PMID: 17570222 DOI: 10.1053/j.gastro.2007.03.045] [Cited by in Crossref: 67] [Cited by in F6Publishing: 65] [Article Influence: 4.8] [Reference Citation Analysis]
36 Bruck R, Schey R, Aeed H, Hochman A, Genina O, Pines M. A protective effect of pyrrolidine dithio-carbamate in a rat model of liver cirrhosis. Liver Int. 2004;24:169-176. [PMID: 15078482 DOI: 10.1111/j.1478-3231.2004.00900.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]